BATS:WDNA WisdomTree BioRevolution Fund (WDNA) Price, Holdings, & News $15.37 +0.23 (+1.52%) (As of 11/22/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatings About WisdomTree BioRevolution Fund (BATS:WDNA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get WDNA alerts:Sign Up Key Stats Today's Range$15.37▼$15.3850-Day Range$14.79▼$17.1052-Week Range N/AVolume165 shsAverage VolumeN/AMarket Capitalization$2.31 millionAssets Under Management$2.30 millionDividend Yield0.86%Net Expense Ratio0.45%Aggregate RatingModerate Buy ETF OverviewThe WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.Read More… Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. WisdomTree BioRevolution Fund ExpensesTypeWDNATheme ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.45%0.57%0.55%0.56%0.52%Other Expenses0.00%0.57%0.49%0.47%0.53%Total Expense0.45%0.72%0.71%0.69%0.71%Fee Waiver0.00%-0.73%-0.52%-0.36%-0.57%Net Expense0.45%0.60%0.61%0.64%0.59% Receive WDNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WisdomTree BioRevolution Fund and its competitors with MarketBeat's FREE daily newsletter. Email Address WDNA ETF News Headlines2024 Superconvergence BioRevolution Series: A New Therapy For Diabetes?October 16, 2024 | seekingalpha.comMoney Market Funds: What Are They and How Do They Work?October 11, 2024 | money.usnews.com50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies. November 23, 2024 | Chaikin Analytics (Ad)Wisdomtree Us Largecap Fund Share Price (EPS.US)September 28, 2024 | lse.co.ukWisdomTree Siegel Longevity DgtlSeptember 27, 2024 | morningstar.comWisdomtree Us Efficient Core Fund Share Price (NTSX.US)September 15, 2024 | lse.co.ukSee More Headlines WDNA ETF - Frequently Asked Questions How have WDNA shares performed this year? WisdomTree BioRevolution Fund's stock was trading at $16.8632 at the beginning of 2024. Since then, WDNA shares have decreased by 8.8% and is now trading at $15.3730. View the best growth stocks for 2024 here. Who are WisdomTree BioRevolution Fund's major shareholders? WisdomTree BioRevolution Fund's top institutional shareholders include Jane Street Group LLC (8.76%). How do I buy shares of WisdomTree BioRevolution Fund? Shares of WDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of WisdomTree BioRevolution Fund own? Based on aggregate information from My MarketBeat watchlists, some other companies that WisdomTree BioRevolution Fund investors own include NIO (NIO), Insight Select Income Fund (INSI), Merck & Co., Inc. (MRK), iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX), ARK Autonomous Technology & Robotics ETF (ARKQ), ARK Genomic Revolution ETF (ARKG) and Ardelyx (ARDX). Fund Details IssuerWisdomTree Fund NameWisdomTree BioRevolution Fund Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:WDNA Inception Date6/3/2021 Fund ManagerMarlene Walker-Smith, Thomas J. Durante WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkWisdomTree BioRevolution Index CategoryStrategy FocusTheme Development LevelDeveloped Markets RegionGlobal Number of Holdings100 Fund Statistics Assets Under Management$2.30 million Average Daily Volume$0.00 Discount/Premium0.01% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorWisdomTree Asset Management, Inc CustodianState Street Bank and Trust Company DistributorForeside Fund Services, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerFlow Traders Miscellaneous Outstanding Shares150,000Beta1.20 Creation Fee$500.00 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Top 10 WDNA HoldingsTwist Bioscience (NASDAQ:TWST)Holding Weight: 3.19%Natera (NASDAQ:NTRA)Holding Weight: 2.90%Agios Pharmaceuticals (NASDAQ:AGIO)Holding Weight: 2.74%Novonesis A/SHolding Weight: 2.61%Blueprint Medicines (NASDAQ:BPMC)Holding Weight: 2.51%Iovance Biotherapeutics (NASDAQ:IOVA)Holding Weight: 2.40%Geron (NASDAQ:GERN)Holding Weight: 2.38%Vericel (NASDAQ:VCEL)Holding Weight: 2.18%Eli Lilly and Company (NYSE:LLY)Holding Weight: 2.10%Veracyte (NASDAQ:VCYT)Holding Weight: 2.03%Full Holdings DetailsWDNA Sector ExposureWDNA Industry Exposure This page (BATS:WDNA) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
